The site goes on to list other beneficial uses, which include: anti-inflammatory activity, blocking cell growth, preventing the growth of blood vessels that supply tumors, antiviral activity and relieving muscle spasms caused by multiple sclerosis.
Several scientific studies have given indications of these beneficial properties in the past, and this past April the US government’s National Institute on Drug Abuse (NIDA) revised their publications to suggest cannabis could shrink brain tumors by killing off cancer cells, stating, “marijuana can kill certain cancer cells and reduce the size of others.”
Research on marijuana’s potential as a medicine has been stifled for decades by federal restrictions, even though nearly half of the states and the District of Columbia have legalized medical marijuana in some form.
Although cannabis has been increasingly legalized by states, the federal
government still classifies marijuana as a Schedule 1 drug — along with
heroin and ecstasy — defining it as having no medical benefits and a
potential for abuse.
The vast majority of the $1.4 billion spent
on marijuana research, by the National Institute of Health, absurdly
involves the study of abuse and addiction, with only $297 million being
spent researching potential medical benefits.
Judging by the spending levels, it seems the feds have a vested interest in keeping
public opinion of cannabis negative. Perhaps “Big Pharma” is utilizing
their financial influence over politicians in an effort to maintain a
stranglehold on the medical treatment market.
Other Cannabis Related New Articles: